Amarin Corp PLC (AMRN)
0.91
-0.01
(-0.87%)
USD |
NASDAQ |
May 03, 16:00
0.9073
0.00 (0.00%)
After-Hours: 20:00
Amarin Free Cash Flow (Quarterly): -1.154M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -1.154M |
September 30, 2023 | 7.328M |
June 30, 2023 | 7.181M |
March 31, 2023 | -7.008M |
December 31, 2022 | 1.552M |
September 30, 2022 | -18.21M |
June 30, 2022 | -64.58M |
March 31, 2022 | -98.85M |
December 31, 2021 | -28.24M |
September 30, 2021 | -4.54M |
June 30, 2021 | -15.05M |
March 31, 2021 | -18.70M |
December 31, 2020 | -38.32M |
September 30, 2020 | 10.85M |
June 30, 2020 | 1.587M |
March 31, 2020 | 3.886M |
December 31, 2019 | -9.30M |
September 30, 2019 | 20.44M |
June 30, 2019 | 15.11M |
March 31, 2019 | -38.09M |
December 31, 2018 | -32.31M |
September 30, 2018 | -28.21M |
June 30, 2018 | -24.44M |
March 31, 2018 | -9.805M |
December 31, 2017 | -2.14M |
Date | Value |
---|---|
September 30, 2017 | -6.277M |
June 30, 2017 | -10.50M |
March 31, 2017 | -13.93M |
December 31, 2016 | -19.31M |
September 30, 2016 | -18.72M |
June 30, 2016 | -8.875M |
March 31, 2016 | -24.93M |
December 31, 2015 | -23.23M |
September 30, 2015 | -22.56M |
June 30, 2015 | -25.62M |
March 31, 2015 | -12.64M |
December 31, 2014 | -15.92M |
September 30, 2014 | -19.88M |
June 30, 2014 | -11.31M |
March 31, 2014 | -27.49M |
December 31, 2013 | -33.08M |
September 30, 2013 | -44.84M |
June 30, 2013 | -52.78M |
March 31, 2013 | -59.65M |
December 31, 2012 | -55.98M |
September 30, 2012 | -39.63M |
June 30, 2012 | -21.56M |
March 31, 2012 | -17.83M |
December 31, 2011 | -11.94M |
September 30, 2011 | -8.301M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-98.85M
Minimum
Mar 2022
20.44M
Maximum
Sep 2019
-12.42M
Average
-4.54M
Median
Sep 2021
Free Cash Flow (Quarterly) Benchmarks
Trinity Biotech PLC | -0.649M |
DBV Technologies SA | -14.04M |
Adaptimmune Therapeutics PLC | -15.50M |
Akari Therapeutics PLC | -- |
Biodexa Pharmaceuticals Plc | -- |